APOE4's beneficial immune function operates through enhanced astrocyte-mediated lipid metabolism and anti-inflammatory signaling, while its AD risk emerges from a microglial-specific gain-of-function that amplifies TREM2-independent lysosomal stress responses, elevates 4-hydroxynonenal (4-HNE) adduct formation, and drives chronic neurotoxic lipid peroxidation during aging. The protective astrocyte effects dominate in acute contexts but decline with age-related metabolic shift, while the pathogenic microglial lipid droplet accumulation becomes progressively more damaging. This cell-type-specific duality explains the apparent paradox: APOE4's immune benefits reflect its astrocyte-mediated anti-inflammatory capacity, while AD risk stems from microglial lipid dyshomeostasis that overwhelms protective mechanisms and accelerates amyloid-independent neurodegeneration through lipid peroxidation chain reactions.
Curated pathway from expert analysis
flowchart TD
A["APOE4 Expression<br/>ApoE4 Protein"]
B["Astrocyte Anti-Inflammatory<br/>Signaling (Beneficial)"]
C["Microglial Lipid<br/>Peroxidation (Pathogenic)"]
D["Dual Function<br/>Conflicting Roles"]
E["Neuroinflammation<br/>Balance"]
F["APOE4 as<br/>Dual-Function Target"]
A --> B
A --> C
B --> D
C --> D
D --> E
E --> F
style B fill:#1b5e20,stroke:#a5d6a7,color:#a5d6a7
style C fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
style F fill:#7b1fa2,stroke:#ce93d8,color:#ce93d8No linked papers recorded for this hypothesis yet.
Median TPM across 13 brain regions for APOE from GTEx v10.
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for APOE.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF microglia-specific N-acetylcysteine (NAC) or 4-HNE scavenger (Welnaczb) is administered via microglia-directed nanocarriers to aged APOE4 knock-in mice for 8 weeks, THEN cortical and hippocampal ne | Significant reduction in soluble neurodegeneration markers and preserved synaptic density (PSD-95, synaptophysin) in NAC/Welnaczb-treated aged APOE4 mice withou | — no observation — | pending | 0.72 |
| IF humanized APOE4 knock-in mice are compared across early adulthood (3-6 months) versus advanced age (18-24 months), THEN astrocyte-derived anti-inflammatory markers (IL-10, TGF-β, APOE secretion) wi | Significant inverse correlation between astrocyte anti-inflammatory capacity and microglial lipid peroxidation burden specifically in aged APOE4 carriers, with | — no observation — | pending | 0.78 |